Related Experiment Video
Updated: Mar 23, 2026

Isolation of Culturable Yeasts and Molds from Soils to Investigate Fungal Population Structure
Published on: May 27, 2022
Role of Antifungal Susceptibility Testing in Non-Aspergillus Invasive Mold Infections
Frédéric Lamoth1,2,3,4, Lauro Damonti3, Barbara D Alexander5,2
1Division of Infectious Diseases and International Health, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA frederic.lamoth@chuv.ch.
Abstract:
No clinical breakpoints are available to delineate antifungal drug efficacy in non-Aspergillus invasive mold infections (NAIMIs). In this analysis of 39 NAIMI episodes, the MIC of the first-line antifungal drug was the most important predictor of therapeutic response. For amphotericin B, an MIC of ≤0.5 μg/ml was significantly associated with better 6-week outcomes.
Related Concept Videos
Antifungal Agents
Fungal Group Zygomycota

